Compound Evidence File
#EC-2026-0265
Testagen
Filed under Peptides. The bureau holds 98 laboratory returns for this compound from 37 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
37 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 10.0 | 9.9 | 10.0 | 7 Feb 2026 | 12 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 10.0 | 9.9 | 10.0 | 22 Dec 2025 | 9 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 9.9 | 10.0 | 16 Jun 2026 | 12 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 10 Mar 2026 | 23 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 10.0 | 10.0 | 1 Nov 2025 | 8 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 9.9 | 10.0 | 14 Mar 2026 | 17 May 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 10.0 | 10.0 | 10.0 | 16 May 2026 | 21 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 10.0 | 10.0 | 10.0 | 15 Apr 2026 | 12 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 9 Dec 2025 | 28 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 9.9 | 9.9 | 10.0 | 3 Apr 2026 | 22 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 9.9 | 9.9 | 9.9 | 18 Nov 2025 | 17 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 9.9 | 4 Jan 2026 | 13 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 24 Mar 2026 | 9 Jun 2026 |
| NextechLabsCASE #VI-2026-0285 | X | 1 | 9.7 | 9.7 | 9.7 | 8 Jul 2025 | 8 Jul 2025 |
| Glamgurcraft Innovations Foreign TradeCASE #VI-2026-0348 | X | 1 | 9.5 | 9.5 | 9.5 | 20 Jun 2025 | 20 Jun 2025 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 9.4 | 9.4 | 9.4 | 2 Apr 2025 | 2 Apr 2025 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 9.3 | 9.3 | 9.3 | 20 Jun 2025 | 20 Jun 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 9.0 | 7.7 | 10.0 | 25 May 2026 | 25 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 7 | 8.9 | 7.6 | 10.0 | 24 May 2026 | 24 May 2026 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | A | 2 | 8.7 | 7.4 | 10.0 | 3 Jun 2025 | 21 May 2026 |
| Huaian Hanyou PeptideCASE #VI-2026-0297 | X | 1 | 8.6 | 8.6 | 8.6 | 11 Jun 2025 | 11 Jun 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.3 | 7.2 | 9.4 | 23 May 2026 | 23 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 8.3 | 7.6 | 9.2 | 23 May 2026 | 23 May 2026 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 8.0 | 8.0 | 8.0 | 25 Apr 2025 | 25 Apr 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 3 | 7.7 | 6.3 | 8.6 | 23 May 2026 | 23 May 2026 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 7.6 | 7.6 | 7.6 | 16 Mar 2025 | 16 Mar 2025 |
| TCICASE #VI-2026-0650 | X | 1 | 7.1 | 7.1 | 7.1 | 28 Mar 2025 | 28 Mar 2025 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | X | 3 | 6.8 | 5.3 | 7.7 | 3 Jun 2025 | 17 May 2026 |
| ZhuoYan labCASE #VI-2026-0902 | X | 3 | 6.4 | 6.1 | 6.9 | 9 Jun 2025 | 21 May 2026 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 4.9 | 4.9 | 4.9 | 28 Mar 2025 | 28 Mar 2025 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 1 | 4.7 | 4.7 | 4.7 | 7 May 2025 | 7 May 2025 |
| Eternal PeptidesCASE #VI-2026-0842 | X | 1 | 4.6 | 4.6 | 4.6 | 9 Jun 2025 | 9 Jun 2025 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 2.6 | 2.6 | 2.6 | 14 Jan 2025 | 14 Jan 2025 |
| Weifang Xingbei International TradeCASE #VI-2026-0766 | X | 1 | 0.8 | 0.8 | 0.8 | 6 May 2025 | 6 May 2025 |
| Coffee and PeppersCASE #VI-2026-0274 | X | 1 | 0.0 | 0.0 | 0.0 | 20 Jun 2025 | 20 Jun 2025 |
Open any subject to view the batch-level evidence for Testagen alone.